Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Net Income (2016 - 2025)

Historic Net Income for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Bristol Myers Squibb's Net Income rose 132894.74% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.1 billion, marking a year-over-year increase of 17898.8%. This contributed to the annual value of $7.1 billion for FY2025, which is 17898.8% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Net Income stood at $1.1 billion, which was up 132894.74% from $2.2 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Net Income ranged from a high of $2.5 billion in Q1 2025 and a low of -$11.9 billion during Q1 2024
  • For the 5-year period, Bristol Myers Squibb's Net Income averaged around $976.1 million, with its median value being $1.6 billion (2022).
  • As far as peak fluctuations go, Bristol Myers Squibb's Net Income surged by 142625.0% in 2021, and later tumbled by 62527.57% in 2024.
  • Bristol Myers Squibb's Net Income (Quarter) stood at $2.4 billion in 2021, then fell by 14.63% to $2.0 billion in 2022, then decreased by 12.99% to $1.8 billion in 2023, then tumbled by 95.69% to $76.0 million in 2024, then skyrocketed by 1328.95% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $2.2 billion for Q3 2025, and $1.3 billion during Q2 2025.